Sujatha Dodoala

Investigating the Effect of Benfotiamine in Paclitaxel-induced Peripheral Neuropathy

Haritha Pasupulati, Satyanarayana SV Padi, Sujatha Dodoala & Prasad VSRG Koganti · Journal of Pharmaceutical Research International · 2026

Background: Chemotherapy-induced peripheral neuropathy (CIPN), particularly due to paclitaxel, remains a dose-limiting adverse effect. Benfotiamine, a lipid-soluble thiamine precursor, has shown anti-inflammatory, antinociceptive, and neuroprotective effects experimentally. Objec...

Open access Research Article 10.9734/jpri/2026/v38i67851

Nuclear PPAR-γ Activation Modulates Inflammation and Oxidative Stress in Attenuating Chemotherapy-Induced Neuropathic Pain in Vivo

Haritha Pasupulati, Satyanarayana S. V. Padi, Sujatha Dodoala & Prasad V. S. R. G. Koganti · Journal of Pharmaceutical Research International · 2021

Background: Paclitaxel-induced painful neuropathy is a major dose-limiting side effect and can persist for up to two years after completing treatment that greatly affects both the course of chemotherapy and quality of life in cancer patients. Peroxisome proliferator-activated rec...

Open access Research Article 10.9734/jpri/2021/v33i38B32112